138231-07-9

Basic information

• Product Name: <3R-(3α,6β,7aα)>-6-methyl-3-phenyl-3H,5H-tetrahydropyrrolo<1,2-c>oxazol-5-one
• Synonyms: <3R-(3α,6β,7aα)>-6-methyl-3-phenyl-3H,5H-tetrahydropyrrolo<1,2-c>oxazol-5-one
• CAS NO: 138231-07-9
• Molecular Weight: 217.268
• Mol File: 138231-07-9.mol
• Article Data: 9

Chemical Properties

• CAS DataBase Reference: <3R-(3α,6β,7aα)>-6-methyl-3-phenyl-3H,5H-tetrahydropyrrolo<1,2-c>oxazol-5-one(CAS DataBase Reference)
• NIST Chemistry Reference: <3R-(3α,6β,7aα)>-6-methyl-3-phenyl-3H,5H-tetrahydropyrrolo<1,2-c>oxazol-5-one(138231-07-9)
• EPA Substance Registry System: <3R-(3α,6β,7aα)>-6-methyl-3-phenyl-3H,5H-tetrahydropyrrolo<1,2-c>oxazol-5-one(138231-07-9)

Safety Data

• Hazardous Substances Data: 138231-07-9(Hazardous Substances Data)

Upstream product

• 100-52-7 benzaldehyde 
• 17342-08-4 (S)-Pyroglutaminol 
• 98-79-3 L-Pyroglutamic acid 
• 7149-65-7 ethyl (S)-pyroglutamate 
• 74-88-4 methyl iodide 
• 103201-79-2 (3R,7aS)-3-phenyl-tetrahydro-pyrrolo[1,2-c]oxazol-5-one 

Downstream Products

• 189618-78-8 N-methyl-3,5-dimethylpyrrolidin-2-one 
• 138231-08-0 <3R-(3α,6α,7aα)>-6-methyl-3-phenyl-3H,5H-tetrahydropyrrolo<1,2-c>oxazol-5-one 
• 180780-71-6 (2S,3S,4S)-2,3-Bis-benzyloxy-4-dimethylamino-5-methoxy-pentanoic acid [(1R,3S)-3-(4-chloromethyl-oxazol-2-yl)-1-methyl-butyl]-amide 
• 138078-58-7 (3S,5S)-5-(hydroxymethyl)-3-methyl-2-pyrrolidinone 

Relevant articles and documents

Stereoselective methylations of bicyclic lactams derived from pyroglutamic acid

Reaction of the lithium enolate of (-)7 with iodomethane provides a stereoselective synthesis of (2R,4S)-4-amino-2-methylpentanamide derivatives.

Compounding method for LCZ696 midbody

The invention discloses a compounding method for a LCZ696 midbody. The compounding route is as follows: wherein R1 is Me, Et or i-Pr; X is Cl, Br or I; R2 is Ms, Ts or Tf. According to the compounding method for the LCZ696 midbody disclosed by the invention, the methylating difficulty is reduced, the midbody is configured and overturned through the consequent reaction, the proportion of the required configuration is greatly increased, the product yield, purity and use ratio are increased and the industrial large-scale production is benefited.

Substituted Piperidines that Increase P53 Activity and the Uses Thereof

In its many embodiments, the present invention discloses novel compounds, as inhibitors of HDM2 protein, methods for preparing such compounds, pharmaceutical compositions including one or more such compounds, methods of treatment, prevention, inhibition, of one or more diseases associated with the HDM2 protein or P53 using such compounds or pharmaceutical compositions.